1999
DOI: 10.1097/00003086-199901000-00015
|View full text |Cite
|
Sign up to set email alerts
|

Local and Systemic Control After Ablative and Limb Sparing Surgery in Patients With Osteosarcoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
77
1
3

Year Published

2002
2002
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 108 publications
(83 citation statements)
references
References 17 publications
2
77
1
3
Order By: Relevance
“…Ewing's sarcoma differs from osteosarcoma in some respects: the mean age of the patients is younger than those with osteosarcoma and seldom occurs beyond the age of 30 years, local control can be achieved with radiation as well as resection, and the drugs used to treat Ewing's sarcoma are different than those used to treat osteosarcoma [3,20,31]. In addition to adequate local control, the use of aggressive polychemotherapy has remarkably improved the survival of patients with Ewing's sarcoma [10,25,32,37] since adjuvant chemotherapy was first introduced in the 1980s and has led to a growing number of long-term survivors [8,20,23]. However, chemotherapy can result in long-term late effects on the cardiac, pulmonary, and metabolic systems as well as on skeletal muscle [16].…”
Section: Introductionmentioning
confidence: 99%
“…Ewing's sarcoma differs from osteosarcoma in some respects: the mean age of the patients is younger than those with osteosarcoma and seldom occurs beyond the age of 30 years, local control can be achieved with radiation as well as resection, and the drugs used to treat Ewing's sarcoma are different than those used to treat osteosarcoma [3,20,31]. In addition to adequate local control, the use of aggressive polychemotherapy has remarkably improved the survival of patients with Ewing's sarcoma [10,25,32,37] since adjuvant chemotherapy was first introduced in the 1980s and has led to a growing number of long-term survivors [8,20,23]. However, chemotherapy can result in long-term late effects on the cardiac, pulmonary, and metabolic systems as well as on skeletal muscle [16].…”
Section: Introductionmentioning
confidence: 99%
“…Other similar series report 5 year survivor ship ranging from 28 % to 76 %. [9] It must be borne in mind there were relatively larger percentage of high grade tumors in our series and also that it includes chondrosarcoma which do have a viable and effective chemotherapy regimen. Currently, 80 % to 85 % of patients with primary malignant bone tumors involving the extremities (osteosarcoma, Ewing's sarcoma, and chondrosarcoma) can be treated safely with wide resection and limb preservation with or without reconstruction.…”
Section: Discussionmentioning
confidence: 85%
“…Currently, 80 % to 85 % of patients with primary malignant bone tumors involving the extremities (osteosarcoma, Ewing's sarcoma, and chondrosarcoma) can be treated safely with wide resection and limb preservation with or without reconstruction. [9] Simon et al [10] published the first evidence-based study supporting the benefits of limb-salvage procedures for the treatment of bone tumors. Their multicenter study, which included 227 patients with osteosarcoma of the distal end of the femur, reported the rates of local recurrence, metastasis, and survival.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Localized tumors limited to the bone of origin have the best prognosis; 5-year survival varies between 60-75% (4,89,90,98,124,134). Patients with metastatic disease (20% at presentation) are typically treated by surgical resection of the primary tumor.…”
Section: Introduction Osteosarcomamentioning
confidence: 99%